LipoEdge Advances Liposomal Magnesium with 80.03% Encapsulation Efficiency

Manufacturing news, posted

 

KOLKATA, India – Nov. 14, 2026 – PRLog — Magnesium plays an essential role in more than 300 enzymatic reactions in the human body, including those associated with muscle function, nerve signalling, cardiovascular health and energy metabolism. Despite its importance, conventional magnesium supplements can present challenges related to absorption, solubility and gastrointestinal tolerance. Advanced liposomal delivery offers a promising approach to address these formulation challenges.

With its LipoEdge Liposomal Technology, West Bengal Chemical Industries Limited (WBCIL) has developed an advanced Liposomal Magnesium formulation, supported by scientific research and comprehensive physicochemical characterisation.

The research, published in the International Journal of Development Research in August 2025, highlights the use of 75% sunflower lecithin as the phospholipid source. The resulting formulation demonstrated a total phospholipid content of 93%, comprising 82.05% phosphatidylcholine and 10.82% phosphatidylethanolamine. These components contribute to the structural integrity of the liposomal bilayer.

One of the key findings was an encapsulation efficiency of 80.03%, indicating effective entrapment of magnesium within the liposomal structure. Further analysis recorded an average particle size of 212.3 nm, a polydispersity index (PDI) of 0.3454 and a zeta potential of -34.83 mV, supporting favourable dispersion characteristics.

Stability was another important focus of the research. During six months of accelerated storage at 40°C ± 2°C and 75% ± 5% relative humidity, encapsulation efficiency remained within 80–81%, with minimal magnesium leakage. Even after exposure to 105°C for four hours, the formulation retained 79% encapsulation efficiency, demonstrating encouraging structural resilience under the tested conditions.

These findings add to the scientific understanding of liposomal magnesium benefits, particularly the potential advantages of phospholipid-based delivery for magnesium retention, formulation stability and gastrointestinal tolerance. The publication also discusses comparative research involving conventional magnesium salts, including magnesium bisglycinate. This provides useful context for manufacturers exploring advanced ingredient formats such as liposomal magnesium bisglycinate.

For nutraceutical and pharmaceutical ingredient developers, LipoEdge focuses on research-led liposomal ingredient development, with attention to encapsulation efficiency, particle characteristics and stability.

Explore LipoEdge Liposomal Magnesium

Discover advanced liposomal ingredient solutions from LipoEdge by WBCIL. Connect with our team to discuss bulk ingredient requirements, technical specifications and customised product development opportunities.

Product: https://www.thelipoedge.com/product/liposomal-pharmaceuticals/liposomal-magnesium/

Explore Scientific Publications: https://www.thelipoedge.com/journals/

Scientific Reference

Gupta Banerjee, P., Paul, A., Chakraborty, A., & Kundu, S. (2025). Superior Formulation Strategy and Advanced Characterisation of Liposomal Magnesium: A Novel Approach by WBCIL. International Journal of Development Research, 15(08), 68830–68838.

DOI: https://doi.org/10.37118/ijdr.29795.08.2025

Contact
LipoEdge
info@thelipoedge.com
06290900900
End

Find out what AI tools say about your company before your buyers do.

Request your Visibility Scorecard
0
0
Your Cart
Your cart is emptyReturn to Shop
Secret Link